Qubigen to Attend Bio-IT World Conference & Expo 2026 in Boston
- 3 days ago
- 2 min read
Qubigen will have an active presence at the Bio-IT World Conference & Expo 2026 in Boston, taking place May 19–21, 2026. Qubigen is pleased to announce that Matthew Oristano, Strategic Advisor and Investor in Qubigen, will be attending with a focus on forging institutional partnerships across the AI-in-Pharma ecosystem.
A Global Hub for Bio-IT Innovation and AI-Driven Drug Discovery
Bio-IT World is a leading global event bringing together leaders from biotechnology, pharmaceuticals, healthcare, data science, and high-performance computing to explore the technologies driving the future of precision medicine. Serving as a central hub for collaboration and innovation, the conference sits at the intersection of AI, big data, and life sciences, with over 200 sessions and dedicated tracks focused on AI-driven discovery, design, and development.
What Qubigen brings to Bio-IT World
Qubigen’s Federated AI Engines enable secure collaboration across institutional data firewalls, allowing sensitive data to remain protected while still contributing to powerful, collaborative models. By combining federated data networks with ultrafast GPU-parallelized quantum chemistry algorithms, Qubigen is working toward the creation of a highly intelligent, disease-agnostic therapeutics platform with unprecedented scale and security.
Let’s Connect in Boston
Qubigen is actively seeking to build meaningful connections across the ecosystem, from scientific partners and drug design collaborators to investors and strategic stakeholders. Matthew Oristano’s participation underscores Qubigen’s commitment to expanding its global network and advancing its platform for Federated AI-enabled Drug Design (FedAIDD).
We look forward to connecting with partners, collaborators, and investors at Bio-IT World 2026, and to continuing to build a federated AI ecosystem for drug design and development, one capable of unlocking novel therapeutics that no single organization could achieve alone.
 | To get in touch with Matt or our team: |
Qubigen - Accelerate Drug Design Without Exposing Secrets
Qubigen builds and hosts powerful, privacy-preserving AI Engines, turning discrete client-specific data into a competitive edge.
Whether you're advancing active programs, reviving dormant data, or starting from scratch, Qubigen’s secure Federated AI, computational modelling and chemistry platform can help you identify, optimize, and accelerate the path to promising lead drug candidates. Get in touch to explore how we can support your next development.